Bloomington’s 2025 economic story is about adapting and rising to meet challenges. Flexibility, strategic investment and ...

Top executives ignored warnings that the company was not sufficiently prepared for the launch of its weight-loss drug Wegovy, ...

Hims & Hers Health continues to eye personalized services and global expansion. Read more on what investors should know about ...

Novo Nordisk has terminated its partnership with telehealth company Hims & Hers Health, accusing it of deceptively marketing weight-loss drugs.

The companies engaged in an increasingly heated war of words on Monday following the drugmaker's decision to end a ...

Novo Nordisk cut off Hims & Hers Health from selling lower-priced Wegovy on Monday morning, but its explanation for the ...

Novo Nordisk on Friday said full results from early-stage trials show that its experimental drug, amycretin, helped overweight and obese adults lose up to 24% of their weight as the Danish company ...

The Connect Transit board has approved the sale of a vacant lot for a planned shelter village in Bloomington. The shelter village, called The Bridge, is intended to be a low-barrier, non-congregate ...

The Bloomington-Normal community will mark Juneteenth on Saturday during an event at Miller Park, featuring live music and dance, activities for kids, and a ceremony commemorating three community ...

Novo Nordisk sees the obesity drug market expanding to $100 billion by 2030. With promising new treatments in the pipeline, 24/7 Wall St. projects huge upside through the end of the decade.

Why to visit this summer: Two words: parking lots. Downtown Bloomington can be a nightmare for those who have to find parking, but in the summer, IU’s lots along Indiana Avenue ease up a bit.

Novo Nordisk has taken initiatives to accelerate target discovery by implementing AI/ML technologies into genetic and human-centric in vitro models. Given the significant costs associated with drug ...